Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.54 |
| ▸ | PRKCA | P17252 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.46 |
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25682108 | 0.89 | NAAA (0.53) | NAAAPRKCALMNATRPV1CNR1 | |
| SCHEMBL4941578 | 0.80 | NAAA (0.68) | NAAAPRKCALMNADGKAMAPT | |
| SCHEMBL23780830 | 0.80 | NAAA (0.51) | NAAAPRKCATRPV1CNR1CNR2 | |
| SCHEMBL23780840 | 0.79 | NAAA (0.50) | NAAAPRKCATRPV1CNR1CNR2 | |
| SCHEMBL28158465 | 0.79 | NAAA (0.66) | NAAAPRKCALMNADGKA | |
| SCHEMBL23780844 | 0.78 | NAAA (0.49) | NAAAPRKCATRPV1CNR1CNR2 | |
| SCHEMBL23780850 | 0.78 | NAAA (0.52) | NAAAPRKCATRPV1CNR1CNR2 | |
| SCHEMBL27130697 | 0.78 | NAAA (0.56) | NAAAPRKCALMNADGKA | |
| SCHEMBL9316078 | 0.78 | NAAA (0.51) | NAAAPRKCALMNATRPV1CNR1 | |
| SCHEMBL8970473 | 0.78 | NAAA (0.51) | NAAAPRKCALMNATRPV1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202875-A1 | SILICON COMPOSITIONS AND METHODS OF PREPARING THE SAME | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202875-A1 | SILICON COMPOSITIONS AND METHODS OF PREPARING THE SAME | NCL, SEPTIN9, SGMS1 | NAAA 2350/4885PRKCA 1986/4885LMNA 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.